Drug Wastage : Observational Study in Intensive Care Units in France
Condition: Drug Use · Sponsor: Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer
About this study
Environmental awareness leads medical field to question its responsibility and possibilities for action. Drug residues can have a major environmental impact as per their bioaccumulation, toxicity and persistence characteristics, depending on where they are discarded. In France, drug residues should be disposed of by incineration, but in practice, this is not systematic. Moreover, data on drug wastage in Intensive Care Units (ICU) are rare. GAME-OVER observational study aims to evaluate drug wastage in ICU in France and to suggest ways to improve health care practices.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (61)
| Centre Hospitalier de Charleville-Mezieres | Charleville-Mézières, Ardennes, France | — |
| CHRU de Strasbourg | Strasbourg, Bas-Rhin, France | — |
| Hôpital Nord | Marseille, Bouches Du Rhône, France | — |
| Centre Hospitalier d'Aurillac | Aurillac, Cantal, France | — |
| Groupe Hospitalier Littoral Atlantique | La Rochelle, Charente-Maritime, France | — |
| CHU de Besançon | Besançon, Doubs, France | — |
| Centre Hospitalier de Montélimar | Montélimar, Drôme, France | — |
| Hôpital privé Claude Galien | Quincy-sous-Sénart, Essonne, France | — |
| HIA Clermont Tonnerre | Brest, Finistère, France | — |
| CHRU de Brest | Brest, Finistère, France | — |
| CHU de Nîmes | Nîmes, Gard, France | — |
| Clinique Saint Augustin | Bordeaux, Gironde, France | — |
+ 49 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05553054